Company profile

Ticker
MDT
Exchange
CEO
Omar S. Ishrak
Employees
Location
Fiscal year end
Former names
Medtronic Holdings Ltd, Medtronic Ltd
SEC CIK

MDT stock data

(
)

Calendar

3 Dec 19
18 Feb 20
24 Apr 20

News

Company financial data Financial data

Quarter (USD) Oct 19 Jul 19 Apr 19 Jan 19
Revenue 7.71B 7.49B 8.15B 7.55B
Net income 1.36B 864M 1.17B 1.27B
Diluted EPS 1.01 0.64 0.87 0.94
Net profit margin 17.70% 11.53% 14.39% 16.82%
Operating income 1.35B 1.49B 1.95B 1.54B
Net change in cash -1.12B 687M 690M -208M
Cash on hand 3.96B 5.08B 4.39B 3.7B
Cost of revenue 2.39B 2.37B 2.48B 2.27B

Financial data from Medtronic earnings reports

80.1% owned by funds/institutions
13F holders
Current Prev Q Change
Total holders 1521 1493 +1.9%
Opened positions 123 124 -0.8%
Closed positions 95 110 -13.6%
Increased positions 626 624 +0.3%
Reduced positions 570 549 +3.8%
13F shares
Current Prev Q Change
Total value 116.64B 105.16B +10.9%
Total shares 1.07B 1.08B -0.5%
Total puts 4.89M 5.53M -11.6%
Total calls 6.14M 6.8M -9.7%
Total put/call ratio 0.8 0.8 -2.2%
Largest owners
Shares Value Change
Vanguard 113.51M $12.33B +1.0%
BLK BlackRock 104.92M $11.4B -2.1%
Wellington Management 73.09M $7.94B +3.6%
STT State Street 57.3M $6.25B -0.7%
Massachusetts Financial Services 54.64M $5.93B -3.4%
Lazard Asset Management 28.16M $3.06B +0.3%
N Price T Rowe Associates 22.73M $2.47B +2.4%
BAC Bank of America 19.9M $2.16B +28.3%
BEN Franklin Resources 18.86M $2.05B -18.5%
Geode Capital Management 18.46M $2B +3.1%
Largest transactions
Shares Bought/sold Change
JHG Janus Henderson 4.57M +4.57M NEW
BAC Bank of America 19.9M +4.39M +28.3%
BEN Franklin Resources 18.86M -4.28M -18.5%
AMP Ameriprise Financial 15.7M +3.49M +28.6%
D. E. Shaw & Co. 1.89M -3.44M -64.5%
Wellington Management 73.09M +2.52M +3.6%
BLK BlackRock 104.92M -2.27M -2.1%
American Century Companies 8.5M -2.23M -20.8%
Capital International Investors 0 -2.15M EXIT
Massachusetts Financial Services 54.64M -1.91M -3.4%

Financial report summary

?
Risks
  • We operate in a highly competitive industry and we may be unable to compete effectively.
  • Reduction or interruption in supply or other manufacturing difficulties may adversely affect our manufacturing operations and related product sales.
  • We are subject to costly and complex laws and governmental regulations and any adverse regulatory action may materially adversely affect our financial condition and business operations.
  • Our failure to comply with laws and regulations relating to reimbursement of health care goods and services may subject us to penalties and adversely impact our reputation, business, results of operations, financial condition and cash flows.
  • We are substantially dependent on patent and other proprietary rights and failing to protect such rights or to be successful in litigation related to our rights or the rights of others may result in our payment of significant monetary damages and/or royalty payments, negatively impact our ability to sell current or future products, or prohibit us from enforcing our patent and other proprietary rights against others.
  • Quality problems and product liability claims could lead to recalls or safety alerts, reputational harm, adverse verdicts or costly settlements, and could have a material adverse effect on our business, results of operations, financial condition and cash flows.
  • Our research and development efforts rely upon investments and investment collaborations, and we cannot guarantee that any previous or future investments or investment collaborations will be successful.
  • Health care policy changes may have a material adverse effect on us.
  • Our insurance program may not be adequate to cover future losses.
  • If we experience decreasing prices for our goods and services and we are unable to reduce our expenses, there may be a material adverse effect on our business, results of operations, financial condition and cash flows.
  • We are subject to a variety of risks associated with global operations that could adversely affect our profitability and operating results.
  • The failure to comply with anti-corruption laws could materially adversely affect our business and result in civil and/or criminal sanctions.
  • Laws and regulations governing international business operations could adversely impact our business.
  • Consolidation in the health care industry could have an adverse effect on our revenues and results of operations.
  • Health care industry cost-containment measures could result in reduced sales of our medical devices and medical device components.
  • We are subject to environmental laws and regulations and the risk of environmental liabilities, violations and litigation.
  • The continuing development of many of our products depends upon us maintaining strong relationships with health care professionals.
  • Our substantial leverage and debt service obligations could adversely affect our business.
  • Failure to integrate acquired businesses into our operations successfully could adversely affect our business.
  • Changes in tax laws or exposure to additional income tax liabilities could have a material impact on our business, results of operations, financial condition and cash flows.
  • The Medtronic, Inc. tax court proceeding outcome could have a material adverse impact on our financial condition.
  • Future potential changes to the U.S. tax laws could result in us being treated as a U.S. corporation for U.S. federal tax purposes, and the IRS may not agree with the conclusion that we should be treated as a foreign corporation for U.S federal income tax purposes.
  • Legislative or other governmental action relating to the denial of U.S. federal or state governmental contracts to U.S. companies that redomicile abroad could adversely affect our business.
  • We are incorporated in Ireland, and Irish law differs from the laws in effect in the U.S. and may afford less protection to holders of our securities.
  • As an Irish public limited company, certain capital structure decisions require shareholder approval, which may limit Medtronic’s flexibility to manage its capital structure.
  • A transfer of our shares, other than ones effected by means of the transfer of book-entry interests in the Depository Trust Company, may be subject to Irish stamp duty.
  • In certain limited circumstances, dividends we pay may be subject to Irish dividend withholding tax and dividends received by Irish residents and certain other shareholders may be subject to Irish income tax.
  • Our shares received by means of a gift or inheritance could be subject to Irish capital acquisitions tax.
Content analysis ?
Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability
H.S. freshman Avg
New words: abolished, aforementioned, amortizable, Artic, BIS, cryoblation, drill, EmployerIdentification, Evout, Flex, Hemorrhagic, NaN, preferential, Stratosphere, Tachy, TAVR, uptake
Removed: absorbable, Aetna, antibacterial, balloon, close, comparative, detailed, Employer, Identification, INFUSE, Labour, meeting, Ministry, Signia, successfully, Welfare

Patents

APP
Utility
Hemostatic Devices and Methods of Use
17 Oct 19
An anchorage device is provided that is configured to surround an implantable medical device.
APP
Utility
Connector Enclosure Assemblies of Medical Devices Including an Angled Lead Passageway
17 Oct 19
Connector enclosure assemblies for medical devices provide an angled lead passageway.
APP
Utility
Medical Devices And/or Lead Extensions Having Fixation Structures with Retained Portions Providing Medical Lead Fixation
17 Oct 19
Medical devices include fixation structures that include retained portions that provide medical lead fixation within the medical devices.
APP
Utility
Method and Apparatus for Detecting Arrhythmias In a Subcutaneous Medical Device
17 Oct 19
A method and system for use with an implantable medical device for subcutaneous implant within a patient to determine a likelihood of the patient experiencing a cardiac event that includes sensing a cardiac signal along a plurality of different sensing vectors, determining state information of each vector of the plurality of sensing vectors, determining a cross correlation of the determined state information of each vector of the plurality of sensing vectors, comparing the cross correlation of the determined state information of each vector of the plurality of sensing vectors to a threshold, and detecting the cardiac event in response to the comparing.
APP
Utility
Resistance Spot Weld Head with Integrated Accelerometer
17 Oct 19
Aspects of this disclosure relate to a welding system that is configured to execute opposed, step, and parallel gap resistance spot welds (RSW) and associated methods.